Pioglitazone
Encyclopedia : P : PI : PIO : Pioglitazone
In medicine and pharmacology, pioglitazone is a member of the drug class of the thiazolidinediones.
It is being marketed as Actos® by the pharmaceutical companies Takeda and Eli Lilly.
Like other thiazolidinediones, its mechanism of action is by activation the intracellular receptor class of the peroxisome proliferator-activated receptors (PPARs), specifically PPARγ.
Side-effects and contraindications
- See main article: thiazolidinedione
See also
External links
- [MedlinePlus article] on pioglitazone.
- [Diabetes monitor] on Pioglitazone
- [Actos / Pioglitazone Fact Sheet]
| Oral antidiabetic drugs (A10B) [http://encycl.opentopia.com/ edit] |
|---|
| ATC_code_A10#A10BA_Biguanides>A10BA - Biguanide - |
| ATC_code_A10#A10BB_Sulfonamides.2C_urea_derivatives>A10BB - Sulfonylureas - |
| ATC_code_A10#A10BF_Alpha_glucosidase_inhibitors>A10BF - Alpha-glucosidase inhibitor - |
| ATC_code_A10#A10BG_Thiazolidinediones>A10BG - Thiazolidinediones (TZD) - |
| ATC_code_A10#A10BX_Other_oral_blood_glucose_lowering_drugs>A10BX - Meglitinide - |
| no ATC - Dipeptidyl peptidase-4 inhibitors>Dipeptidyl peptidase-4 (DPP-4) inhibitors - |
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.